GEODE CAPITAL MANAGEMENT, LLC - TOKAI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TOKAI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$70,000
-16.7%
84,831
-1.7%
0.00%
Q4 2016$84,000
-25.7%
86,328
+16.4%
0.00%
Q3 2016$113,000
-64.6%
74,171
+27.9%
0.00%
Q2 2016$319,000
+8.5%
57,977
+10.3%
0.00%
Q1 2016$294,000
-35.8%
52,554
-0.1%
0.00%
Q4 2015$458,000
-13.4%
52,619
+2.8%
0.00%
Q3 2015$529,000
-7.4%
51,191
+19.1%
0.00%
Q2 2015$571,000
+26.3%
42,995
+7.3%
0.00%
Q1 2015$452,000
-18.4%
40,088
+6.7%
0.00%
Q4 2014$554,00037,5850.00%
Other shareholders
TOKAI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Green Owl Capital Management, LLC 130,000$1,729,0001.23%
Novo Holdings A/S 1,238,252$16,469,0001.18%
Perceptive Advisors 485,338$6,455,0000.39%
KINGDON CAPITAL MANAGEMENT, L.L.C. 740,978$9,855,0000.38%
Tourbillon Capital Partners, L.P. 517,000$6,876,0000.15%
SABBY MANAGEMENT, LLC 128,041$1,703,0000.06%
Alyeska Investment Group, L.P. 613,134$8,154,0000.05%
ROPES WEALTH ADVISORS LLC 6,000$80,0000.04%
OPPENHEIMER & CO INC 12,048$160,0000.00%
FRANKLIN RESOURCES INC 451,700$6,008,0000.00%
View complete list of TOKAI PHARMACEUTICALS INC shareholders